Oncimmune Company

Biomarker proprietary platform to test for cancer cell signatures, during/post therapy.
Technology: AgeTech Companies
Industry: Healthcare (Diagnostic Tool)
Headquarters: United Kingdom
Founded Date: 2006-01-01
Funding Status: M&A
Total Funding: $6 818 006
Estimated Revenue: Less than $1M
Last Funding Date: 2017-09-27
Last Funding Type: Post-IPO Equity

Visit Website
https://twitter.com/OncimmuneECDT
Register and Claim Ownership